LEO Pharma Investigational Site

Washington D.C., District of Columbia 20037

1 studies enrolling now · 1 studies all time

What they study most

Lichen Sclerosus

Studies at this site

• A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus — Recruiting now